I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Holland, Jaymes
19
results:
Search for persons
X
Format
Online (19)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (10)
Sorted by: Relevance
Sorted by: Year
?
1
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic ..:
Basch, Ethan M.
;
Scholz, Mark
;
de Bono, Johann S.
...
European Urology. 75 (2019) 6 - p. 929-937 , 2019
Link:
https://doi.org/10.1016/..
?
2
Volumetric response quantified using T1 subtraction predict..:
Ellingson, Benjamin M
;
Aftab, Dana T
;
Schwab, Gisela M
...
Neuro-Oncology. 20 (2018) 10 - p. 1411-1418 , 2018
Link:
https://doi.org/10.1093/..
?
3
Phase II study of cabozantinib in patients with progressive..:
Wen, Patrick Y
;
Drappatz, Jan
;
de Groot, John
...
Neuro-Oncology. 20 (2017) 2 - p. 249-258 , 2017
Link:
https://doi.org/10.1093/..
?
4
Phase II study of cabozantinib in patients with progressive..:
Cloughesy, Timothy F
;
Drappatz, Jan
;
de Groot, John
...
Neuro-Oncology. 20 (2017) 2 - p. 259-267 , 2017
Link:
https://doi.org/10.1093/..
?
5
Effect of Renal and Hepatic Impairment on the Pharmacokinet..:
Nguyen, Linh
;
Holland, Jaymes
;
Ramies, David
...
The Journal of Clinical Pharmacology. 56 (2016) 9 - p. 1130-1140 , 2016
Link:
https://doi.org/10.1002/..
?
6
Pharmacokinetic (PK) drug interaction studies of cabozantin..:
Nguyen, Linh
;
Holland, Jaymes
;
Miles, Dale
...
The Journal of Clinical Pharmacology. 55 (2015) 9 - p. 1012-1023 , 2015
Link:
https://doi.org/10.1002/..
?
7
Evaluation of the effect of food and gastric pH on the sing..:
Nguyen, Linh
;
Holland, Jaymes
;
Mamelok, Richard
...
The Journal of Clinical Pharmacology. 55 (2015) 11 - p. 1293-1302 , 2015
Link:
https://doi.org/10.1002/..
?
8
A randomised comparison of deferasiroxversusdeferoxamine fo..:
Vichinsky, Elliott
;
Onyekwere, Onyinye
;
Porter, John
...
British Journal of Haematology. 136 (2006) 3 - p. 501-508 , 2006
Link:
https://doi.org/10.1111/..
?
9
First‐in‐human, phase I study of PF‐06647263, an anti‐EFNA4..:
Garrido‐Laguna, Ignacio
;
Krop, Ian
;
Burris III, Howard A.
...
International Journal of Cancer. 145 (2019) 7 - p. 1798-1808 , 2019
Link:
https://doi.org/10.1002/..
?
10
Cabozantinib versus mitoxantrone-prednisone in symptomatic ..:
Basch, Ethan
;
Scholz, Mark
;
De Bono, Johann S
...
European Urology--0302-2838--1873-7560 Vol. 75 Issue. 6 pp: 929-937. , 2019
Link:
https://doi.org/10.1016/..
?
11
Phase II study of cabozantinib in patients with progressive..:
Wen, Patrick Y
;
Drappatz, Jan
;
de Groot, John
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777496/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
12
Phase II study of cabozantinib in patients with progressive..:
Cloughesy, Timothy F
;
Drappatz, Jan
;
de Groot, John
...
qt4078k2j9. , 2018
Link:
https://escholarship.org..
?
13
Volumetric response quantified using T1 subtraction predict..:
Ellingson, Benjamin M
;
Aftab, Dana T
;
Schwab, Gisela M
...
qt66j537hb. , 2018
Link:
https://escholarship.org..
?
14
Phase II study of cabozantinib in patients with progressive..:
Cloughesy, Timothy F
;
Drappatz, Jan
;
de Groot, John
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777491/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
15
Phase II study of cabozantinib in patients with progressive..:
Wen, Patrick Y
;
Drappatz, Jan
;
de Groot, John
...
qt1bw9z93f. , 2018
Link:
https://escholarship.org..
1-15
